Tiziana Life Sciences to Present at BTIG’s Virtual Biotechnology Conference
August 11 2020 - 4:00AM
Tiziana Life Sciences plc (Nasdaq: TLSA / AIM: TILS) (“Tiziana” or
the “Company”), a clinical stage biotechnology company developing
targeted drugs for cancer, inflammatory diseases and COVID-19,
announced that members of its management team will participate
virtually in the BTIG Biotechnology Conference on Tuesday,
August 11, 2020 at 2:30 p.m. EDT.
To access a live webcast of the fireside chat
please register for the BTIG Biotechnology Conference, using the
link here. The investor presentation can be found
on the Tiziana website, here. A replay of the
webcast will be archived on Tiziana’s website for approximately 45
days following the presentation.
About Tiziana Life Sciences
Tiziana Life Sciences plc is a dual listed
(NASDAQ: TLSA & UK AIMS: TILS) biotechnology company that
focuses on the discovery and development of novel molecules to
treat human diseases in oncology, inflammation and infectious
diseases. In addition to milciclib, the Company will be shortly
initiating phase 2 studies with orally administered foralumab for
Crohn’s Disease and nasally administered foralumab for progressive
multiple sclerosis. Foralumab is the only fully human anti-CD3
monoclonal antibody (mAb) in clinical development in the world.
This phase II compound has potential application in a wide range of
autoimmune and inflammatory diseases, such as Crohn’s Disease,
multiple sclerosis, type-1 diabetes (T1D), inflammatory bowel
disease (IBD), psoriasis and rheumatoid arthritis, where modulation
of a T-cell response is desirable. The company is accelerating
development of anti-Interleukin 6 receptor (IL6R) mAb, a fully
human monoclonal antibody for treatment of IL6-induced
inflammation, especially for treatment of COVID-19 patients.
Investor Contact:
RedChip Companies, Inc. Dave Gentry 407-491-4498
dave@redchip.com
Tiziana Life Sciences (NASDAQ:TLSA)
Historical Stock Chart
From Aug 2024 to Sep 2024
Tiziana Life Sciences (NASDAQ:TLSA)
Historical Stock Chart
From Sep 2023 to Sep 2024